Cadila Healthcare board to consider unaudited financial result

20 Jan 2014 Evaluate

Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on February 07, 2014, inter alia, to consider & approve the unaudited financial results for the quarter/nine months ended on December 31, 2013. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from January 29, 2014 to February 08, 2014 for all Directors and designated officers of the Company.

The above information is a part of company’s filings submitted to BSE

Zydus Lifesciences Share Price

901.30 -2.70 (-0.30%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×